AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST

The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	XIAO, Yushi, YU, Tao, MCCORMICK, Kevin D, WU, Heping, ZHANG, Yonglian, KUANG, Rongze, LO, Michael Man-Chu, LIM, Yeon-Hee, XIAO, Dong, TING, Pauline C, WU, Jie, TAGAT, Jayaram R, KIM, David Won-Shik, ALI, Amjad, DEGRADO, Sylvia J, ZHU, Xiaohong, CAO, Jianhua, LEE, Joe F, KHAN, Tanweer, HENDERSON, Timothy J, TUNG, Alexander L, KIM, Jae-Hun, HONG, Liwu, RUIZ, Manuel de Lera, BIJU, Purakkattle, BERLIN, Michael, ZHOU, Gang
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.